Chief Executive Officer

• Aug 2023 - Present

Board Director & Advisor

• Dec 2022 - Present

Co-Founder & CEO

• Aug 2020 - Nov 2022

Reducing Life-threatening and Disabling Hemorrhagic Conditions Thanks to an innovative mechanism of action to inhibit fibrinolysis, our patented preclinical candidate is aiming to address a number of significant unmet medical needs in trauma, surgery, ICH, PPH, GI bleeding and in several bleeding disorders (Rare Diseases). Trauma Civilian & Military - Surgery - ICH - Gynecology - Rare Diseases - GI Bleeding

Founder & Managing Partner

• Jun 2019 - Present

Driving Healthcare Innovation from Tech Scouting to Venture Building Our mission is to accompany innovative technologies from science bench to business success in areas of high unmet medical need. We are an established interdisciplinary team of experienced executives, consultants, doctors, investors and financial advisors who perform an in-depth due diligence process to advance the most promising life-changing technologies. Patents Scouting - Venture Building - Funding - M&A -… Show more Driving Healthcare Innovation from Tech Scouting to Venture Building Our mission is to accompany innovative technologies from science bench to business success in areas of high unmet medical need. We are an established interdisciplinary team of experienced executives, consultants, doctors, investors and financial advisors who perform an in-depth due diligence process to advance the most promising life-changing technologies. Patents Scouting - Venture Building - Funding - M&A - Licensing – Scaling Show less Driving Healthcare Innovation from Tech Scouting to Venture Building Our mission is to accompany innovative technologies from science bench to business success in areas of high unmet medical need. We are an established interdisciplinary team of experienced executives, consultants, doctors, investors and financial advisors who perform an in-depth due diligence process to advance the most promising life-changing technologies. Patents Scouting - Venture Building - Funding - M&A -… Show more Driving Healthcare Innovation from Tech Scouting to Venture Building Our mission is to accompany innovative technologies from science bench to business success in areas of high unmet medical need. We are an established interdisciplinary team of experienced executives, consultants, doctors, investors and financial advisors who perform an in-depth due diligence process to advance the most promising life-changing technologies. Patents Scouting - Venture Building - Funding - M&A - Licensing – Scaling Show less

Advisor & Investor

• Aug 2020 - Present

The Future of Telemedicine Intelligent. Frictionless. Impactful. Give your customers the most accessible telemedicine solution. The Future of Telemedicine Intelligent. Frictionless. Impactful. Give your customers the most accessible telemedicine solution.

Advisor & Investor

• Nov 2021 - Present

Co-Founder & CEO

• Oct 2021 - Oct 2023

Expanding the Power of Exosomes for Diagnostic and Therapeutic Applications We have developed a patented technology based on synthetic chemosensors for the efficient isolation of exosomes and other circulating microvesicles from biological fluids (urine, plasma, etc.) for use in the diagnosis and prognosis of diseases. By not targeting a specific biomarker and with a simpler laboratory process which preserves the integrity of exosomes, we provide a broader set of applications… Show more Expanding the Power of Exosomes for Diagnostic and Therapeutic Applications We have developed a patented technology based on synthetic chemosensors for the efficient isolation of exosomes and other circulating microvesicles from biological fluids (urine, plasma, etc.) for use in the diagnosis and prognosis of diseases. By not targeting a specific biomarker and with a simpler laboratory process which preserves the integrity of exosomes, we provide a broader set of applications both for diagnostic and therapeutic purposes, across multiple health conditions. Exosomes - At-home Diagnostics - Therapeutics - Isolation kits - Blood Purifying - Diagnostic Kits Show less Expanding the Power of Exosomes for Diagnostic and Therapeutic Applications We have developed a patented technology based on synthetic chemosensors for the efficient isolation of exosomes and other circulating microvesicles from biological fluids (urine, plasma, etc.) for use in the diagnosis and prognosis of diseases. By not targeting a specific biomarker and with a simpler laboratory process which preserves the integrity of exosomes, we provide a broader set of applications… Show more Expanding the Power of Exosomes for Diagnostic and Therapeutic Applications We have developed a patented technology based on synthetic chemosensors for the efficient isolation of exosomes and other circulating microvesicles from biological fluids (urine, plasma, etc.) for use in the diagnosis and prognosis of diseases. By not targeting a specific biomarker and with a simpler laboratory process which preserves the integrity of exosomes, we provide a broader set of applications both for diagnostic and therapeutic purposes, across multiple health conditions. Exosomes - At-home Diagnostics - Therapeutics - Isolation kits - Blood Purifying - Diagnostic Kits Show less

Venture Partner

• Jul 2019 - Sep 2020

Partner

• Mar 2016 - Jun 2019

SkyPath Capital Partners is an innovation focused strategy advisory firm and private investment boutique focused on growth and funding strategy for technology and technology enabled industries including: (i) fintech / insurtech; (ii) SaaS / enterprise software; (iii) artificial intelligence; (iv) healthtech; (v) blockchain protocols / DApps, (vi) green tech; and (vii) real estate tech / proptech.

M&A Advisory and Principal Investing

• 2002 - 2002

M&A Advisory and equity investor (advising Macquarie's funds). M&A Advisory and equity investor (advising Macquarie's funds).

M&A Advisory

• 2000 - 2002

M&A execution at Schroder Salomon Smith Barney (SSSB). M&A execution at Schroder Salomon Smith Barney (SSSB).

Senior Auditor

• 1998 - 2000

M&A Financial due diligence and statutory audit. M&A Financial due diligence and statutory audit.